"Biotech startups patented nearly two-thirds of new drugs in 2018, and in their early stages they rely almost entirely on venture capital. Later they often cooperate with or license their discoveries to large drug makers. Only about 15% of drugs and vaccines that enter clinical trials are approved. The rate for oncology therapies is 3%.
We enter an era of great biotech discovery. The hugely successful mRNA Covid vaccines are the result of years and billions of dollars in research. BioNTech initially set out to create cancer vaccines and linked up with Pfizer in 2018 to work on a more effective flu vaccine. Biotech firms are trying to use mRNA technology for personalized cancer vaccines, autoimmune treatments and gene therapies." [1]
1. The Political Raid on Future Cures
Wall Street Journal, Eastern edition; New York, N.Y. [New York, N.Y]. 17 Sep 2021: A.16.
Komentarų nėra:
Rašyti komentarą